Haemonetics Corporation Gross Profit 2009–2026
Haemonetics Corporation reported $787.59M of gross profit for fiscal 2026. That was 5.2% higher than fiscal 2025. Compared with fiscal 2021, the change was +98.0%.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2026 | $787.59M | 59.0% | +5.2% |
| FY 2025 | $748.96M | 55.0% | +8.3% |
| FY 2024 | $691.55M | 52.8% | +12.4% |
| FY 2023 | $615.10M | 52.6% | +21.7% |
| FY 2022 | $505.50M | 50.9% | +27.1% |
| FY 2021 | $397.84M | 45.7% | -17.9% |
| FY 2020 | $484.51M | 49.0% | +16.0% |
| FY 2019 | $417.54M | 43.2% | +1.4% |
| FY 2018 | $411.91M | 45.6% | +8.8% |
| FY 2017 | $378.49M | 42.7% | -6.8% |
| FY 2016 | $405.91M | — | -6.6% |
| FY 2015 | $434.42M | 47.7% | -7.2% |
| FY 2014 | $468.37M | 49.9% | +9.4% |
| FY 2013 | $428.13M | 48.0% | +15.9% |
| FY 2012 | $369.24M | 50.7% | +4.0% |
| FY 2011 | $355.21M | 52.5% | +5.3% |
| FY 2010 | $337.48M | 52.3% | +9.5% |
| FY 2009 | $308.17M | — | — |
Source: Haemonetics Corporation SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open HAE 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Haemonetics Corporation reported $787.59M of gross profit for fiscal 2026. That was 5.2% higher than fiscal 2025. Compared with fiscal 2021, the change was +98.0%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Haemonetics Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHaemonetics Corporation — frequently asked questions
What is Haemonetics Corporation's gross profit?
Haemonetics Corporation (HAE) reported gross profit of $787.59M for fiscal year 2026, per its SEC filings.
How has Haemonetics Corporation's gross profit changed over time?
Between fiscal 2009 and 2026, HAE's gross profit grew at roughly 5.7% per year (compound annual rate), from $308.17M to $787.59M.
Where does this data come from?
Figures are computed from Haemonetics Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.